A Study to Evaluate Effectiveness of Sublobar Dissection in Patients With Non-small Cell Lung Cancer
A Multi-centre Real-world Non-interventional Observational Study to Evaluate Effectiveness of Sublobar Dissection in the Chinese Patients With Non-small Cell Lung Cancer
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100029
- China-Japan Friendship Hospital
-
Beijing, Beijing, China, 100853
- China PLA General Hospital
-
-
Henan
-
Zhengzhou, Henan, China, 450003
- Henan Cancer Hospital
-
-
Hubei
-
Wuhan, Hubei, China, 430030
- Tongji Hospital Affiliated to Huazhong Technology Hospital
-
-
Jiangsu
-
Nanjing, Jiangsu, China, 210009
- Jiangsu Cancer Hospital
-
-
Shaanxi
-
Xi'an, Shaanxi, China, 710000
- Xi'an Tangdu Hospital
-
-
Shanghai
-
Shanghai, Shanghai, China, 200030
- Shanghai Chest Hospital
-
-
Sichuan
-
Chengdu, Sichuan, China, 610041
- Huaxi Hospital Affiliated to Sichuan University
-
-
Tianjin
-
Tianjin, Tianjin, China, 300051
- Tianjin Chest Hospital
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310003
- First Hospital Affiliated to Zhejiang University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients >= 18 years old;
- Patients who received sublobar dissection from 2014 to 2017 (segment dissection/wedge dissection/segment and wedge dissections);
- Patients who received selective or systematic lymphadenectomy;
- Pathologically diagnosed patients with non-small cell lung cancer;
- Pathological staging: I, II
Exclusion Criteria:
- Patients who received cancer treatments before surgeries (adjuvant therapies including chemotherapies, radiotherapies, target therapies);
- Patients who received late-phase or intolerant palliative lobectomy or compromise sublobar dissection;
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Sublobar dissection
Chinese NSCLC patients who received sublobar dissection
|
Sublobar dissection plus lymphadenectomy
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survival
Time Frame: 2014 - 2017
|
Overall survival
|
2014 - 2017
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall survivals in subgroups
Time Frame: 2014 - 2017
|
Overall survivals categorised by tumor biological characteristics
|
2014 - 2017
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Impact factors of overall survival
Time Frame: 2014 - 2017
|
Impact factors of overall survival as measured by patient demographic/tumor biological characteristics and clinical treatments
|
2014 - 2017
|
|
Death rates after surgeries
Time Frame: 2014 - 2017
|
Death rates after surgeries
|
2014 - 2017
|
|
Impact factors of death rates after surgeries
Time Frame: 2014 - 2017
|
Impact factors of death rates after surgeries
|
2014 - 2017
|
|
Incidence of complications after surgeries
Time Frame: 2014 - 2017
|
Incidence of complications after surgeries
|
2014 - 2017
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Principal Investigator: Xiangning Fu, PhD, Tongji Hospital Affiliated to Tongji Medical College Huazhong Technology University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- TJ-LC-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.